Skip to content

Prof. Midena Edoardo

Ophthalmologist, Researcher
Head of Research Unit in Ocular Oncology and Toxicology
Midena Edoardo
Research line: Research Line of Oncology and Ocular Toxicology
Research unit: RU Ocular Oncology and Toxicology
Specialization: Ophthalmology
Professional register: Provincial Register of Physicians and Surgeons of Padua (Order of the Province of Padua), No. 6085 dated 13 October 1987

Scientific Publications: PubMed

 

  • Degree in Medicine and Surgery and specialization in Ophthalmology at the University of Padua
  • Full Professor of Eye Diseases and Director of the Ophthalmology Clinic and the School of Specialization in Ophthalmology at the University of Padua (Department of Neuroscience – DNS).
  • 2015 – present: Director, School of Specialization in Ophthalmology, University of Padua
  • 2007 – present: Director, Ophthalmology Clinic, University Hospital of Padua
  • 2006 – present: Full Professor of Eye Diseases, University of Padua
  • 2001 – 2007: Associate Professor of Ophthalmology, University of Padua, and Director, Ocular Oncology Service, Ophthalmology Clinic, University Hospital of Padua

  • Member of the Scientific Committee, G.B. Bietti Foundation IRCCS, Rome

  • Member of the National Commission for Blindness Prevention, Italy

  • Member of the Executive Board, EURETINA

  • Member, Club Jules Gonin

  • Member, Retina Society

  • Member, Macula Society

  • Member, European Academy of Ophthalmology

  • Member, EURETINA

  • Member, EVER (European Association for Vision and Eye Research)

  • Member, OOG (Oncology Ophthalmology Group)

  • Member, ISOO (International Society of Ocular Oncology)

  • Secretary General and National Representative, European Board of Ophthalmology (the leading cultural institution in ophthalmology in Europe)

  • Secretary General, Italian Retina Society

  • Member of the Executive Board, EURETINA

  • Fellow, Association for Research in Vision and Ophthalmology (ARVO)

He is Principal Investigator in numerous international clinical trials on innovative drugs for the treatment of macular diseases.

Prof. Midena serves as reviewer for the following journals:

  • Investigative Ophthalmology and Visual Science

  • Ophthalmology

  • British Journal of Ophthalmology

  • Graefe’s Archives of Clinical and Experimental Ophthalmology

  • Cancer

  • European Journal of Ophthalmology

  • Ophthalmic Research

  • Drugs

  • Acta Ophthalmologica Scandinavica

  • Cases & Reports

  • He is Invited Editor of the journal Current Eye Research and member of the Editorial Board of Retinal Cases & Brief Reports, Ophthalmologica and International Ophthalmology.

  • He is author or co-author of 241 publications featured in leading international ophthalmology journals, and of more than 300 scientific works overall.

He received the European Leadership Development Award from the European Society of Ophthalmology and the Awardfrom the American Academy of Ophthalmology.

Skip to content